AI-generated summary
The authors conducted a secondary analysis of a randomized trial in 122 adults with nonseasonal major depression receiving light therapy, fluoxetine, combination, or placebo. They report that baseline appetitive symptoms predicted treatment response differently across groups, with more appetitive symptoms linked to less improvement in the placebo group and more improvement in the active treatment groups. The authors note the group sizes were modest and the findings are preliminary only.
- Participants
- 122
- Who or what was studied
- Adults with nonseasonal major depressive disorder (DSM-IV-TR criteria) without a seasonal pattern
- Limits stated in the abstract
- The authors state that group sample sizes were modest, so the findings should be considered preliminary only, and the light-only association was not robust.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on psychiatrist.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Effect size, Bright light therapy, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.